Galmed Pharma (GLMD) Tops Q2 EPS by 5c
Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.33), $0.05 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.33), $0.05 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.